effect of continued weekly subcutaneous semaglutide Ozempic Weight Loss Reality: Not a Miracle Solution Pharmacokinetic properties of once-weekly subcutaneous

Supplies Needed Plan based on daily use protocol: Peptide Vials (Ipamorelin 10mg): 8 weeks approx

Actual results could differ materially from those described or implied by such forward-looking statements as a result of various important risks and uncertainties, including, without limitation, the initiation and design of any future clinical trials will be impacted by Skye's capital resources, Skye's ability to obtain additional sources of capital needed to run an additional Phase 2 clinical trial, program considerations and potentially other factors outside the Skye's control

Endpoint Definitions and Statistical Approach The primary endpoint was MACE, defined as all-cause mortality, myocardial infarction, or stroke, assessed over 52 weeks using an as-treated design

Semaglutide Semaglutide mimics GLP-1, a gut hormone thats released naturally after you eat

Both medications represent FDA-approved approaches to medical weight management, but they work through completely different mechanisms